As we expected, although cell viability decreased with increasing E/T ratios, GBM cells expressing TRAF3 were more susceptible to CD8+ T cell–mediated killing in comparison with control group cells (Figure 8E and Supplemental Figure 8C). The gene discussed is CD8A; the disease is glioblastoma.